SEC Filing Summary: Vencor, Inc. (Form 10-K)
Business Context and Reporting Period
Company: Vencor, Inc.
Reporting Period: Fiscal Year Ended December 31, 1995
Business Overview: Vencor is a diversified healthcare provider focusing on the elderly, operating an integrated network of long-term intensive care hospitals, nursing centers, contract services (Vencare), pharmacies, and retirement communities. A pivotal event in 1995 was the merger with The Hillhaven Corporation (completed September 28, 1995), which significantly expanded the company's scale. The financial statements reflect the combined operations of Vencor, Hillhaven, and Nationwide Care, Inc. (acquired by Hillhaven in June 1995) using the pooling-of-interests method.
Key Financial Metrics
| Metric | 1995 | 1994 | 1993 |
|---|---|---|---|
| Total Revenues | $2,323.96 million | $2,032.83 million | $1,727.44 million |
| Net Income (Loss) | $(14.89) million | $85.90 million | $65.66 million |
| Income from Operations | $8.36 million | $86.14 million | $68.98 million |
| Cash Flow from Operations | $113.64 million | $133.04 million | $105.24 million |
| Long-Term Debt | $778.10 million | $746.21 million | $784.80 million |
| Working Capital | $239.67 million | $129.08 million | $114.34 million |
| Stockholders' Equity | $772.06 million | $596.45 million | $485.55 million |
Revenue Composition (1995): Nursing centers contributed 66.3% ($1.54 billion), Hospitals 19.6% ($456 million), Pharmacies 7.7% ($178 million), Vencare 4.7% ($110 million), and Retirement Communities 2% ($46 million).
Material Changes vs. Prior Period
- Net Loss vs. Profit: The company reported a net loss of $14.9 million in 1995, a sharp decline from the $85.9 million net income in 1994. This was primarily driven by non-recurring charges totaling $128.4 million (pretax) related to the Hillhaven Merger, including investment fees, severance costs, and property disposition losses.
- Revenue Growth: Consolidated revenues increased 14.3% year-over-year, driven by the Hillhaven and Nationwide mergers and organic growth in hospital patient days (up 21%) and Vencare contracts (up 112% to 2,008 contracts).
- Debt Restructuring: The company established a new $1 billion credit facility to refinance higher-rate debt and fund the merger. It also redeemed all outstanding convertible debt securities in Q4 1995, resulting in an extraordinary loss of $23.3 million (net of tax) on extinguishment of debt.
- Liquidity: Working capital improved significantly to $239.7 million from $129.1 million in 1994, supported by the new credit facility.
Guidance, Outlook, and Risks
Management Outlook: Management anticipates achieving significant operating synergies from the Hillhaven Merger, estimating a potential increase in pretax income of approximately $100 million annually by 1997 through cost reductions and increased patient referrals. Capital expenditures for 1996 are projected at $175 million (excluding acquisitions).
Key Risks and Contingencies:
- Regulatory Environment: The company is heavily dependent on Medicare and Medicaid reimbursement (approx. 63% of total revenues). Changes in federal or state regulations, cost-containment measures, or reimbursement rates could materially impact profitability.
- Healthcare Reform: Ongoing legislative proposals regarding healthcare reform and federal budget balancing could reduce government spending on Medicare and Medicaid.
- Integration Risks: Significant efforts are required to integrate the Hillhaven and Nationwide operations; failure to realize synergies could adversely affect results.
- Legal Proceedings: Pending litigation related to the Horizon Healthcare Corporation's attempted acquisition of Hillhaven, though management believes resolution will not have a material adverse effect.
Investor Verification Checklist
- Non-Recurring Charges: Verify the magnitude and nature of the $128.4 million merger-related charges to assess the underlying operational performance (adjusted income from operations was $101.9 million).
- Reimbursement Rates: Monitor changes in Medicare and Medicaid reimbursement policies, as these programs constitute the majority of revenue.
- Debt Covenants: Review compliance with the new $1 billion credit facility covenants, which limit additional debt and stock purchases.
- Accounts Receivable: Assess the growth in outstanding days of revenue in accounts receivable, which has adversely impacted cash flows due to integration delays and payment delays from state Medicaid programs.
- Merger Synergies: Track progress on cost-saving initiatives and revenue growth from the integrated network to validate the $100 million annual synergy target.